BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25263443)

  • 1. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
    Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
    J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
    Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
    PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptide receptor a promotes gastric malignancy through angiogenesis process.
    Li Z; Fan H; Cao J; Sun G; Sen Wang ; Lv J; Xuan Z; Xia Y; Wang L; Zhang D; Xu H; Xu Z
    Cell Death Dis; 2021 Oct; 12(11):968. PubMed ID: 34671022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
    Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM
    J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells.
    Heo SC; Kwon YW; Jang IH; Jeong GO; Yoon JW; Kim CD; Kwon SM; Bae YS; Kim JH
    Stem Cells; 2014 Mar; 32(3):779-90. PubMed ID: 24155208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.
    Kim SY; Ko YS; Park J; Choi Y; Park JW; Kim Y; Pyo JS; Yoo YB; Lee JS; Lee BL
    Cancer Res Treat; 2016 Jan; 48(1):345-54. PubMed ID: 25761483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo.
    de Paulis A; Prevete N; Rossi FW; Rivellese F; Salerno F; Delfino G; Liccardo B; Avilla E; Montuori N; Mascolo M; Staibano S; Melillo RM; D'Argenio G; Ricci V; Romano M; Marone G
    J Immunol; 2009 Sep; 183(6):3761-9. PubMed ID: 19692643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin promotes angiogenesis by activating HIF-1α/β-catenin/VEGF signaling in gastric cancer.
    Tang E; Wang Y; Liu T; Yan B
    Gene; 2019 Jul; 704():42-48. PubMed ID: 30980943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
    Hou XL; Ji CD; Tang J; Wang YX; Xiang DF; Li HQ; Liu WW; Wang JX; Yan HZ; Wang Y; Zhang P; Cui YH; Wang JM; Bian XW; Liu W
    Sci Rep; 2017 Jun; 7(1):3153. PubMed ID: 28600569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.
    Li SQ; Su N; Gong P; Zhang HB; Liu J; Wang D; Sun YP; Zhang Y; Qian F; Zhao B; Yu Y; Ye RD
    Sci Rep; 2017 Jul; 7(1):5918. PubMed ID: 28724995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
    Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
    FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
    Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
    Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth.
    Prevete N; Liotti F; Marone G; Melillo RM; de Paulis A
    Pharmacol Res; 2015 Dec; 102():184-91. PubMed ID: 26466865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis.
    Huang YC; Huang FI; Mehndiratta S; Lai SC; Liou JP; Yang CR
    Oncotarget; 2015 Jul; 6(21):18590-601. PubMed ID: 26087180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.